| CONTENTS |
| Medusa: an Innovative Formulation Approach to Improve Pharmacokinetic & Safety Profiles of Biotherapeutics Dr You-Ping Chan, Director of Chemistry & Analytical Research Dr Remi Meyrueix, Director of Formulation of Injectable Platform Camille Rivail, & Business Development Analyst Dr Jean Chatellier, Vice-President Alliance Management Flamel Technologies, SA |
| Novel Polymers for Enhancing Therapeutic Half-life & Drug Targeting Dr Jill Ogden, Vice-President of Business Development Dr Richard Palmer, Executive Chairman Warwick Effect Polymers, Ltd |
| The IVECT Method: Intezyne�s Versatile Encapsulation & Crosslinking Technology as a Platform for Drug Delivery Dr Adam Carie, Senior Scientist, Preclinical Development Dr Jonathan Rios-Doria, Manager, Preclinical Studies Dr Habib Skaff, CEO Dr Kevin Sill, CSO Intezyne, Inc |
| Enhanced Drug Delivery to the Brain: Safe & Versatile Mr Willem van Weperen, CEO Dr Pieter Gaillard, CSO to-BBB technologies, BV |